Certified by Founder Lodge
Cellarity
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $121,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 04 ,2022 | Series C | $121,000,000 |
Hanwha Impact Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
